Allarity Therapeutics Granted Japanese Patent for Stenoparib DRPĀ® Companion Diagnostic, Further Strengthening Stenoparib Development

Go back to Allarity Therapeutics Granted Japanese Patent for Stenoparib DRPĀ® Companion Diagnostic, Further Strengthening Stenoparib Development
(NASDAQ: ALLR) Delayed: 0.87 +0.02 (2.35%)
Previous Close $0.85    52 Week High $ 
Open $0.84    52 Week Low $ 
Day High $0.90    P/E N/A 
Day Low $0.84    EPS $ 
Volume 71,070